Systemic administration of rIL-33 in melanoma tumor bearing mice, promoted expansion, increased tumor infiltration and effector function of antigen-specific CD8+ IFN-γ+ T cells by both a direct or DCs-mediated effect (50). This evidence concerns the gene CD8A and melanoma.